MORRISTOWN, N.J. and BORNEM, Belgium – Capsugel’s Dosage Form Solutions (DFS) business unit unveiled extensive upgrades and expansions to three of its manufacturing facilities in the United States and Europe, deepening the company’s finished dosage form capabilities as part of its LIPIDEX® technology platform. The multi-million dollar investments broaden the company’s global capabilities to handle hormonal as well as high- potent compounds for soft gelatin and ...